E-ISSN 2277-338X
 

Original Research
Online Published: 07 Feb 2017
 


Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus

.


Cited By:1

Abstract
No abstract available


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

. Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus. Int J Med Sci Public Health. 2017; 6(6): 992-995. doi:10.5455/ijmsph.2017.1268827012017


Web Style

. Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus. https://www.ijmsph.org/?mno=252991 [Access: June 23, 2026]. doi:10.5455/ijmsph.2017.1268827012017


AMA (American Medical Association) Style

. Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus. Int J Med Sci Public Health. 2017; 6(6): 992-995. doi:10.5455/ijmsph.2017.1268827012017



Vancouver/ICMJE Style

. Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus. Int J Med Sci Public Health. (2017), [cited June 23, 2026]; 6(6): 992-995. doi:10.5455/ijmsph.2017.1268827012017



Harvard Style

(2017) Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus. Int J Med Sci Public Health, 6 (6), 992-995. doi:10.5455/ijmsph.2017.1268827012017



Turabian Style

. 2017. Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus. International Journal of Medical Science and Public Health, 6 (6), 992-995. doi:10.5455/ijmsph.2017.1268827012017



Chicago Style

. "Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus." International Journal of Medical Science and Public Health 6 (2017), 992-995. doi:10.5455/ijmsph.2017.1268827012017



MLA (The Modern Language Association) Style

. "Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus." International Journal of Medical Science and Public Health 6.6 (2017), 992-995. Print. doi:10.5455/ijmsph.2017.1268827012017



APA (American Psychological Association) Style

(2017) Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus. International Journal of Medical Science and Public Health, 6 (6), 992-995. doi:10.5455/ijmsph.2017.1268827012017